Analysis Article • May 29
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedJun 27, 2026
DataAggregated Company Financials
Companies104
- 7D-8.3%
- 3M-44.1%
- 1Y-3.7%
- YTD-25.5%
Over the last 7 days, the Pharma industry has dropped 8.3%, driven by Sam Chun Dang Pharm declining 17%. In contrast, Hanall Biopharma has gained 14%. Overall the industry is down 3.7% in 12 months. Earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 27 Jun 2026 | ₩52.6t | ₩32.7t | ₩2.1t | 9.5x | 25.1x | 1.6x |
| Mon, 25 May 2026 | ₩68.2t | ₩32.5t | ₩1.9t | 12.7x | 36.1x | 2.1x |
| Wed, 22 Apr 2026 | ₩75.6t | ₩32.3t | ₩1.8t | 14.8x | 42.3x | 2.3x |
| Fri, 20 Mar 2026 | ₩84.3t | ₩31.6t | ₩1.5t | 13.9x | 56x | 2.7x |
| Sun, 15 Feb 2026 | ₩84.8t | ₩31.4t | ₩1.2t | 16x | 71.6x | 2.7x |
| Tue, 13 Jan 2026 | ₩71.2t | ₩31.4t | ₩1.2t | 16.3x | 60.1x | 2.3x |
| Thu, 11 Dec 2025 | ₩73.1t | ₩31.4t | ₩1.2t | 15x | 61.9x | 2.3x |
| Sat, 08 Nov 2025 | ₩66.9t | ₩31.4t | ₩1.1t | 17.9x | 63.7x | 2.1x |
| Mon, 06 Oct 2025 | ₩64.4t | ₩31.3t | ₩1.0t | 20.3x | 64.1x | 2.1x |
| Wed, 03 Sep 2025 | ₩58.9t | ₩31.1t | ₩928.8b | 19x | 63.4x | 1.9x |
| Fri, 01 Aug 2025 | ₩58.2t | ₩30.4t | ₩918.0b | 17.5x | 63.4x | 1.9x |
| Sun, 29 Jun 2025 | ₩53.0t | ₩30.2t | ₩914.7b | 16.1x | 58x | 1.8x |
| Tue, 27 May 2025 | ₩53.4t | ₩29.8t | ₩938.3b | 19.4x | 56.9x | 1.8x |
| Thu, 24 Apr 2025 | ₩53.2t | ₩29.6t | ₩984.4b | 17.7x | 54x | 1.8x |
| Sat, 22 Mar 2025 | ₩53.8t | ₩29.7t | ₩927.6b | 13.7x | 58x | 1.8x |
| Mon, 17 Feb 2025 | ₩56.2t | ₩29.5t | ₩1.0t | 11.7x | 56x | 1.9x |
| Wed, 15 Jan 2025 | ₩56.4t | ₩29.6t | ₩1.0t | 12.9x | 55.5x | 1.9x |
| Fri, 13 Dec 2024 | ₩51.5t | ₩29.4t | ₩994.1b | 11.7x | 51.8x | 1.7x |
| Sun, 10 Nov 2024 | ₩58.2t | ₩28.7t | ₩841.1b | 15x | 69.2x | 2x |
| Tue, 08 Oct 2024 | ₩59.7t | ₩28.7t | ₩833.2b | 15.1x | 71.6x | 2.1x |
| Thu, 05 Sep 2024 | ₩58.3t | ₩28.8t | ₩837.9b | 15.3x | 69.6x | 2x |
| Sat, 03 Aug 2024 | ₩53.7t | ₩28.4t | ₩762.2b | 14x | 70.4x | 1.9x |
| Mon, 01 Jul 2024 | ₩51.9t | ₩30.0t | ₩904.2b | 13.2x | 57.4x | 1.7x |
| Wed, 29 May 2024 | ₩52.2t | ₩30.1t | ₩897.6b | 14.8x | 58.2x | 1.7x |
| Fri, 26 Apr 2024 | ₩50.8t | ₩29.4t | ₩922.9b | 16.5x | 55x | 1.7x |
| Sun, 24 Mar 2024 | ₩55.5t | ₩30.1t | ₩890.9b | 21.4x | 62.3x | 1.8x |
| Tue, 20 Feb 2024 | ₩52.2t | ₩29.6t | ₩593.1b | 21.1x | 88x | 1.8x |
| Thu, 18 Jan 2024 | ₩51.8t | ₩29.6t | ₩592.3b | 22.4x | 87.5x | 1.8x |
| Sat, 16 Dec 2023 | ₩50.6t | ₩29.6t | ₩588.2b | 21.5x | 86x | 1.7x |
| Mon, 13 Nov 2023 | ₩48.3t | ₩29.3t | ₩683.4b | 16.7x | 70.7x | 1.6x |
| Wed, 11 Oct 2023 | ₩50.4t | ₩29.3t | ₩683.3b | 17.1x | 73.7x | 1.7x |
| Fri, 08 Sep 2023 | ₩50.1t | ₩29.3t | ₩683.9b | 15.9x | 73.3x | 1.7x |
| Sun, 06 Aug 2023 | ₩51.8t | ₩28.8t | ₩884.1b | 22.2x | 58.6x | 1.8x |
| Tue, 04 Jul 2023 | ₩47.5t | ₩28.8t | ₩899.2b | 20.7x | 52.8x | 1.6x |
Price to Earnings Ratio
52.8x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 25.1x which is lower than its 3-year average PE of 63.2x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 33% per year over the last three years.
- Revenues for these companies have grown 4.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -7.37% | |
| Healthcare | -6.10% | |
| Pharma | -8.33% | |
| Pharma | -8.33% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A009420 Hanall Biopharma | ₩57.80k | 13.8% +₩355.5b | 136.9% | PS18.5x | |
| A179530 ADBiotech | ₩2.45k | 10.4% +₩22.3b | -26.9% | PS5.3x | |
| A034940 ChoA Pharmaceutical | ₩735.00 | 45.0% +₩7.1b | -28.2% | PS0.4x | |
| A067290 JW Shinyak | ₩2.41k | 3.2% +₩4.2b | 56.1% | PE9.8x | |
| A229500 NovMetaPharma | ₩8.40k | 3.7% +₩3.9b | -19.8% | n/a |